Asia-Pacific is emerging as a strategic hub for global clinical trials, with the market expected to grow at 7.3% CAGR through 2030. But navigating APAC’s diverse regulatory and cultural landscape requires deep local insight and trusted guidance.
Dr. Yooni Kim, Novotech’s Managing Director – Asia Pacific, shares how strong regional expertise, operational excellence, and investment in local talent are helping sponsors overcome challenges and unlock the region’s full potential.
Read the full article to see why APAC is no longer a backup region—but a powerhouse for global clinical research success.